Answers are grounded in this paper and cite their sources.
Skeletal muscle mass (SMM) plays a crucial role in risk assessment in transcatheter aortic valve replacement (TAVR) candidates, yet it remains underutilized. Traditional methods focus on weakness or performance but omit SMM. This study compared traditional and novel markers of sarcopenia and frailty in terms of their ability to predict adverse outcomes post-TAVR.
No takes yet. Share an insight, caveat, or question.
Persits et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: